BioMed Research International / 2014 / Article / Fig 1

Research Article

The Antileukemia Activity of Natural Product HQ17(3) Is Possibly Associated with Downregulation of miR-17-92 Cluster

Figure 1

Viability for leukemia cells treated with HQ17(3). K562, Molt-4, Ramos, and U937 were treated with various doses of HQ17(3) for 24 h. The cells were then subjected to viability assay using a CellQuanti-Blue kit. The viability of blank is designated to be 100%. The experiments were conducted in triplicate. Means ± SD are shown.

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.